Potassium ion (gastrointestinal lumen) (K+)

Potassium ions in the gastrointestinal lumen represent a critical physiological pool for maintaining systemic electrolyte homeostasis, particularly when renal clearance is impaired (Palmer & Carrero, 2021). While potassium is primarily absorbed in the small intestine, the distal colon serves as a site for both absorption and active secretion, regulated by various transporters and channels (National Kidney Foundation, 2023). In patients with chronic kidney disease (CKD) or heart failure, the gastrointestinal tract becomes an increasingly important route for potassium elimination (Weir et al., 2015). Therapeutic intervention targeting luminal potassium involves the use of non-absorbed cation-exchange polymers or inorganic crystals that bind potassium ions in exchange for other cations like sodium, calcium, or hydrogen (FDA Label: Veltassa, 2015). By sequestering potassium within the gut lumen, these agents prevent its absorption into the bloodstream and promote its excretion via feces, thereby effectively lowering serum potassium levels (Kosiborod et al., 2014). This approach is vital for managing patients on renin-angiotensin-aldosterone system (RAAS) inhibitors, who are at high risk for life-threatening hyperkalemia (Palmer & Carrero, 2021). However, clinicians must monitor for safety concerns such as hypokalemia and gastrointestinal disturbances like constipation or bowel necrosis (Harel et al., 2013).

Other names

Luminal potassiumGastrointestinal potassiumK+ ionFecal potassium

Cation exchange within the gastrointestinal lumen to sequester potassium and increase its fecal excretion (FDA Label: Veltassa, 2015; FDA Label: Lokelma, 2018).